CDT Equity Inc. (CDT) vs Jupiter Neurosciences, Inc. (JUNS)
A side-by-side comparison of CDT Equity Inc. and Jupiter Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDT
CDT Equity Inc.
$0.88HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
JUNS
Jupiter Neurosciences, Inc.
$2.50HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — CDT vs JUNS
growth of $100 · dividends reinvested · last 2yCDT -100.0% (-99.9%/yr)JUNS -99.3% (-91.7%/yr)JUNS compounded faster over this window
Log scale — wide-divergence pair
CDT JUNS
CDT vs JUNS: by the numbers
- •JUNS is the larger company ($1M vs $680476 market cap).
- •CDT is profitable (6.30% net margin) while JUNS runs a net loss (-14220.12%).
Metrics side by side
Valuation
| Metric | CDT | JUNS |
|---|---|---|
| P/S ratio | 0.00 | 18.73 |
| P/B ratio | 0.00 | N/A |
| EV / EBITDA | 4.13 | N/A |
Profitability
| Metric | CDT | JUNS |
|---|---|---|
| Gross margin | 0.00% | 88.34% |
| Operating margin | 0.00% | -40873.19% |
| Net margin | 6.30% | -14220.12% |
| ROE | 6.58% | N/A |
| ROIC | 4.47% | -709.40% |
Growth (annualized)
| Metric | CDT | JUNS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -47.77% |
Frequently asked
- Is CDT or JUNS more profitable?
- CDT runs the higher net margin — CDT at 6.30% versus JUNS at -14220.12%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.